188 related articles for article (PubMed ID: 18067629)
1. Update on actinic keratosis in clinical trial experience with imiquimod.
Ferrándiz C
Br J Dermatol; 2007 Dec; 157 Suppl 2():32-3. PubMed ID: 18067629
[TBL] [Abstract][Full Text] [Related]
2. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
[TBL] [Abstract][Full Text] [Related]
3. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
Stockfleth E; Sterry W; Carey-Yard M; Bichel J
Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
[TBL] [Abstract][Full Text] [Related]
4. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients.
Ulrich C; Bichel J; Euvrard S; Guidi B; Proby CM; van de Kerkhof PC; Amerio P; Rønnevig J; Slade HB; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2(Suppl 2):25-31. PubMed ID: 18067628
[TBL] [Abstract][Full Text] [Related]
5. Gene expression in actinic keratoses: pharmacological modulation by imiquimod.
Lysa B; Tartler U; Wolf R; Arenberger P; Benninghoff B; Ruzicka T; Hengge UR; Walz M
Br J Dermatol; 2004 Dec; 151(6):1150-9. PubMed ID: 15606509
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod for actinic keratosis: systematic review and meta-analysis.
Hadley G; Derry S; Moore RA
J Invest Dermatol; 2006 Jun; 126(6):1251-5. PubMed ID: 16557235
[TBL] [Abstract][Full Text] [Related]
7. New and emerging topical approaches for actinic keratoses.
Del Rosso JQ
Cutis; 2003 Oct; 72(4):273-6, 279. PubMed ID: 14604078
[TBL] [Abstract][Full Text] [Related]
8. [Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
Oster-Schmidt C; Altmeyer P; Markus S
J Dtsch Dermatol Ges; 2003 Oct; 1(10):790-6. PubMed ID: 16281815
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
Stockfleth E; Meyer T; Benninghoff B; Christophers E
Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
[TBL] [Abstract][Full Text] [Related]
10. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of action of new treatment modalities for actinic keratosis.
Berman B; Villa AM; Ramirez CC
J Drugs Dermatol; 2006 Feb; 5(2):167-73. PubMed ID: 16485885
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
[TBL] [Abstract][Full Text] [Related]
13. Topical therapy for actinic keratoses: current and evolving therapies.
Weinberg JM
Rev Recent Clin Trials; 2006 Jan; 1(1):53-60. PubMed ID: 18393780
[TBL] [Abstract][Full Text] [Related]
14. Summary of actinic keratosis studies with imiquimod 5% cream.
Tran H; Chen K; Shumack S
Br J Dermatol; 2003 Nov; 149 Suppl 66():37-9. PubMed ID: 14616347
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod - Its role in the treatment of cutaneous malignancies.
Bubna AK
Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
[TBL] [Abstract][Full Text] [Related]
16. [Actinic keratosis].
Dissemond J; Grabbe S
MMW Fortschr Med; 2006 Jun; 148(24):38-9, 41. PubMed ID: 16850807
[TBL] [Abstract][Full Text] [Related]
17. Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel.
Berman B; Bienstock L; Kuritzky L; Mayeaux EJ; Tyring SK; ;
J Fam Pract; 2006 May; 55(5):suppl 1-8. PubMed ID: 16672155
[No Abstract] [Full Text] [Related]
18. Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses.
D'Addario S; Carrington PR
Acta Derm Venereol; 2006; 86(4):366-7. PubMed ID: 16874431
[No Abstract] [Full Text] [Related]
19. Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.
Lonergan CL; McNamara EK; Cordoro KM; Greer KE
Cutis; 2010 Apr; 85(4):199-202. PubMed ID: 20486460
[TBL] [Abstract][Full Text] [Related]
20. Apparent clinical resolution of pinnal actinic keratoses and squamous cell carcinoma in a cat using topical imiquimod 5% cream.
Peters-Kennedy J; Scott DW; Miller WH
J Feline Med Surg; 2008 Dec; 10(6):593-9. PubMed ID: 18417398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
